Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Sell · Filed 24/03/21

Trade details

Type: Insider sale
Amount: $8,813.28
Shares · price: 976 sh · $9.03 a share
Held after: 1,746,471 sh
Stock: ARS Pharmaceuticals SPRY
Person: Richard E. LowenthalPresident and CEO
Trade date: 24/03/19
Filed: 24/03/21
Days to filing: 2 days

Sold 0.1% of holdings

Share of holding sold: 0.1%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/02/18~24/04/18

Richard E. Lowenthal's recent trades

Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$177K
35,000 sh
$177K
Filed 09/11
Traded 09/11
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$421.1K
75,000 sh
$421.1K
Filed 09/04
Traded 09/04
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$115.6K
19,805 sh
$115.6K
Filed 09/03
Traded 09/03
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$5,000
840 sh
$5,000
Filed 09/02
Traded 09/02
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$148.2K
25,000 sh
$148.2K
Filed 08/20
Traded 08/20